The EU is facing shortages of 16 critical medicines due to production issues, increased demand, and market withdrawals. The European Medicines Agency (EMA) reports ongoing shortages of 34 medicines, with efforts underway to address these through the Critical Medicines Act. Key medicines in short supply include Cyanokit for cyanide poisoning, Amoxicillin for bacterial infections, inhalers for respiratory conditions, various insulin types, cancer drugs, a vaccine for Japanese encephalitis, and treatments for blood diseases, schizophrenia, heart attack prevention, and eye problems. Teljes cikk (Euronews.com)